Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion.

MLA

Batist, G., et al. “Phase I and Pharmacokinetic Study of Tiazofurin (TCAR, NSC 286193) Administered by Continuous Infusion.” Investigational New Drugs, vol. 3, no. 4, 1985, pp. 349–55. EBSCOhost, https://doi.org/10.1007/BF00170757.

APA

Batist, G., Klecker, R. W., Jr, Jayaram, H. N., Jenkins, J. F., Grygiel, J., Ihde, D. C., Eddy, J. L., Fine, R. L., Kerr, I. G., & Collins, J. M. (1985). Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion. Investigational New Drugs, 3(4), 349–355. https://doi.org/10.1007/BF00170757

Chicago

Batist, G, R W Klecker Jr, H N Jayaram, J F Jenkins, J Grygiel, D C Ihde, J L Eddy, R L Fine, I G Kerr, and J M Collins. 1985. “Phase I and Pharmacokinetic Study of Tiazofurin (TCAR, NSC 286193) Administered by Continuous Infusion.” Investigational New Drugs 3 (4): 349–55. doi:10.1007/BF00170757.